首页> 美国卫生研究院文献>BMJ Case Reports >Case Report: Flupirtine drug-induced liver injury in a patient developing acute liver failure
【2h】

Case Report: Flupirtine drug-induced liver injury in a patient developing acute liver failure

机译:病例报告:氟吡汀药物引起的急性肝衰竭患者肝损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A patient is admitted with complaints of recent onset nausea, discomfort, jaundice and blood tests that reveal severe hepatitis. At the time, she had been taking medication with (St John’s wort) for 6 months, and 6 weeks before this event, she took flupirtine maleate. A few days after being admitted, she developed encephalopathy progressing to acute liver failure (ALF) requiring unsuccessful liver transplantation. The patient was ultimately diagnosed with drug-induced liver injury (DILI). In this context, while could interfere with other medication or trigger DILI itself, flupirtine appears to have triggered the DILI, given its liver toxicity capacity. DILI is one of the major ALF causes and can jeopardise patient’s life. Accordingly, all efforts to reduce medication potentially hazardous to the liver are recommended.
机译:病人因最近发作的恶心,不适,黄疸和血液检查显示出严重的肝炎而入院。当时,她已经和(圣约翰草)一起服药了6个月,而在此事件发生前的6星期,她服用了氟吡汀马来酸盐。入院几天后,她发展为脑病,进展为急性肝衰竭(ALF),需要肝移植失败。该患者最终被诊断出患有药物性肝损伤(DILI)。在这种情况下,尽管氟吡汀可能干扰其他药物或触发DILI本身,但鉴于其肝毒性,它似乎已经触发了DILI。 DILI是ALF的主要病因之一,可能会危及患者的生命。因此,建议采取一切措施减少可能对肝脏有害的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号